Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,046 public trials 269 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

NCT07220616

Conditions: B-Cell Non-Hodgkin Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: Research Site New York, United States

Research Site Lille, France

Research Site Pierre-Bénite, France

Research Site Nagoya, Japan

View Trial Details

Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

NCT01772771

Conditions: Glioma, Hematologic Diseases, Hematologic Neoplasms, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions: AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

UCLA Health - Bowyer Oncology Center Los Angeles, California, United States

UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States

View all 45 locations

View Trial Details

Recruiting

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

NCT05110742

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

NCT07007312

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

University of California, Fresno Clovis, California, United States

University of California, San Diego La Jolla, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

View all 115 locations

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

NCT05463796

Conditions: Adenocarcinoma, Adenomatous Hyperplasia, Adult Cancer Survivors, +79 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

NCT04515810

Conditions: Death, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Northwell Health Manhasset, New York, United States

Mount Sinai Hospital New York, United States

NYP/Weill Cornell Medical Center New York, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

NCT06184321

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

John Hopkins University Baltimore, Maryland, United States

View Trial Details

Recruiting

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

NCT02203903

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Childrens National Medical Center Washington D.C., District of Columbia, United States

Tania Jain, MD Baltimore, Maryland, United States

View Trial Details